Skip to content
Back to ENTX

Entera Bio Ltd.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
8
Purchases
8
Sales
0
Purchase value
$140.88K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Geno J GermanoDirector
4
Filed Mar 11, 2026Period of report Mar 9, 20260001178913-26-000825
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 9, 2026
Ordinary Shares, par value NIS 0.0000769 per share20,000$1.30$26.00K40,000Direct
Open on SEC EDGAR
Sean EllisDirector
4
Filed Mar 9, 2026Period of report Mar 5, 20260001178913-26-000787
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 5, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF110,000$1.23$12.30K188,098Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2287 to $1.245 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Steven D RubinDirector
4
Filed Feb 17, 2026Period of report Feb 12, 20260001178913-26-000508
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 12, 2026
Ordinary Shares, par value NIS 0.0000769 per share5,000$1.49$7.45K15,000Direct
Open on SEC EDGAR
Haya TaitelDirector
4
Filed Feb 11, 2026Period of report Feb 10, 20260001178913-26-000414
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 10, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF17,500$1.48$11.10K—Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.4799 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Geno J GermanoDirector
4
Filed Feb 11, 2026Period of report Feb 10, 20260001178913-26-000413
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 10, 2026
Ordinary Shares, par value NIS 0.0000769 per share20,000$1.49$29.80K—Direct
Open on SEC EDGAR
Steven D RubinDirector
4
Filed Feb 11, 2026Period of report Feb 9, 20260001178913-26-000412
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 9, 2026
Ordinary Shares, par value NIS 0.0000769 per share10,000$1.20$12.00K10,000Direct
Open on SEC EDGAR
Sean EllisDirector
4
Filed Feb 11, 2026Period of report Feb 9, 20260001178913-26-000411
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 9, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF118,000$1.24$22.32K178,098Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.299 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Miranda Jayne ToledanoDirector · Chief Executive Officer
4
Filed Dec 30, 2025Period of report Dec 29, 20250001178913-25-004125
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 29, 2025
Ordinary Shares, par value NIS 0.0000769 per shareF111,000$1.8102$19.91K426,575Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.82, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.